MX394035B - Procedimiento para preparar una proteina de fusion tnfr-fc que contiene un contenido objetivo de impurezas. - Google Patents
Procedimiento para preparar una proteina de fusion tnfr-fc que contiene un contenido objetivo de impurezas.Info
- Publication number
- MX394035B MX394035B MX2017008633A MX2017008633A MX394035B MX 394035 B MX394035 B MX 394035B MX 2017008633 A MX2017008633 A MX 2017008633A MX 2017008633 A MX2017008633 A MX 2017008633A MX 394035 B MX394035 B MX 394035B
- Authority
- MX
- Mexico
- Prior art keywords
- tnfr
- hydrophobic
- fusion protein
- chromatogram peak
- content
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Chemical Kinetics & Catalysis (AREA)
Abstract
La presente invención se refiere a un procedimiento para preparar una mezcla de proteína de fusión TNFR-Fc que comprende un contenido objetivo de pico 3 de cromatografía hidrofóbica, y a un procedimiento para ajustar un contenido de pico 3 de cromatografía hidrofóbica. Específicamente, la presente invención se refiere (a) a un procedimiento para preparar una mezcla de proteína de fusión TNFR-Fc usando un medio de cromatografía de interacción hidrofóbica que contiene un grupo funcional aromático, que está pre-equilibrado con un tampón de equilibrio que comprende cloruro de sodio o sulfato de amonio, y una muestra que comprende una mezcla líquida de proteína de fusión TNFR-Fc producida a partir de células de mamífero, y a un procedimiento para ajustar el contenido de pico 3 de cromatografía hidrofóbica por cromatografía hidrofóbica usando un tampón de equilibrio que contiene una concentración predeterminada de cloruro de sodio o de sulfato de amonio. La presente invención puede proporcionar un procedimiento para preparar una proteína de fusión TNFR-Fc usando en la producción de la proteína de fusión TNFR-Fc cromatografía hidrofóbica, realizando cromatografía hidrofóbica mediante la equilibración usando un tampón de equilibrio que contiene una concentración predeterminada de cloruro de sodio o de sulfato de amonio, de ese modo ajustando el contenido de pico 3 de cromatografía hidrofóbica para contener un contenido objetivo de pico 3 de cromatograma hidrofóbico. Por lo tanto, el procedimiento presentado anteriormente puede ser usado favorablemente en la fabricación de medicamentos biológicos que comprenden una proteína recombinante, tal como etanercept producido a partir de cultivos de células animales, mediante tecnología genética recombinante.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20140195766 | 2014-12-31 | ||
| PCT/KR2015/014393 WO2016108569A1 (ko) | 2014-12-31 | 2015-12-29 | 목적하는 함량으로 불순물을 포함하는 tnfr-fc 융합 단백질의 제조방법 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2017008633A MX2017008633A (es) | 2018-04-26 |
| MX394035B true MX394035B (es) | 2025-03-21 |
Family
ID=56284628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017008633A MX394035B (es) | 2014-12-31 | 2015-12-29 | Procedimiento para preparar una proteina de fusion tnfr-fc que contiene un contenido objetivo de impurezas. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10988527B2 (es) |
| EP (1) | EP3241849A4 (es) |
| JP (2) | JP6793996B2 (es) |
| KR (1) | KR102018608B1 (es) |
| AU (1) | AU2015372801B2 (es) |
| BR (1) | BR112017014224A2 (es) |
| IL (1) | IL253218B (es) |
| MX (1) | MX394035B (es) |
| RU (1) | RU2670166C1 (es) |
| SA (1) | SA517381861B1 (es) |
| WO (1) | WO2016108569A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11952399B2 (en) * | 2018-12-18 | 2024-04-09 | Amgen Inc. | Methods for purifying proteins |
| AU2022354256A1 (en) * | 2021-09-28 | 2024-04-11 | Kashiv Biosciences, Llc | An improved process for purification of fusion protein |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7294481B1 (en) * | 1999-01-05 | 2007-11-13 | Immunex Corporation | Method for producing recombinant proteins |
| EP1885488B1 (en) * | 2005-05-24 | 2015-07-08 | GE Healthcare Bio-Sciences AB | Regeneration of a chromatography matrix |
| JP2010516651A (ja) | 2007-01-17 | 2010-05-20 | メルク セローノ ソシエテ アノニム | Fc含有タンパク質の精製のための方法 |
| CA2784959C (en) | 2010-01-22 | 2018-06-26 | Boehringer Ingelheim International Gmbh | Chromatographic method for purifying fc-containing proteins |
| CN102382190B (zh) * | 2010-09-01 | 2014-04-09 | 山东新时代药业有限公司 | 分离和去除TNFR-Fc融合蛋白中寡聚体的方法 |
| EP2678030A4 (en) * | 2011-02-25 | 2015-02-18 | Merck Sharp & Dohme | PREPARATION OF N- AND O-SIALYLATED TNFRII-FC FUSION PROTEINS IN YEAST |
| WO2012176158A1 (en) | 2011-06-24 | 2012-12-27 | Dr. Reddy's Laboratories Limited | Purification of chimeric protein |
| BR112014000352A2 (pt) | 2011-07-08 | 2017-02-14 | Merck Sharp & Dohe Corp | método de purificar uma proteína de fusão-fc, proteínas de fusão contendo fc purificada, tnfr:fc purificada, e tnfr:fc elevadamente purificada |
| WO2013025079A1 (en) | 2011-08-17 | 2013-02-21 | Hanwha Chemical Corporation | Method for preparing active form of tnfr-fc fusion protein |
| CN104011073B (zh) | 2011-10-18 | 2017-08-25 | 科荣生生物科学公司 | 使用氨基酸稳定的依那西普制剂 |
| RS57013B1 (sr) * | 2012-09-11 | 2018-05-31 | Coherus Biosciences Inc | Korektno savijeni etanercept sa visokom čistoćom i odličnim prinosom |
| WO2014102814A1 (en) * | 2012-12-31 | 2014-07-03 | Intas Biopharmaceuticals Limited | Process for the purification of fc fusion proteins |
-
2015
- 2015-12-29 RU RU2017124181A patent/RU2670166C1/ru active
- 2015-12-29 JP JP2017535373A patent/JP6793996B2/ja active Active
- 2015-12-29 MX MX2017008633A patent/MX394035B/es unknown
- 2015-12-29 EP EP15875663.5A patent/EP3241849A4/en active Pending
- 2015-12-29 BR BR112017014224-4A patent/BR112017014224A2/pt not_active Application Discontinuation
- 2015-12-29 US US15/541,111 patent/US10988527B2/en active Active
- 2015-12-29 IL IL253218A patent/IL253218B/en unknown
- 2015-12-29 KR KR1020150188455A patent/KR102018608B1/ko active Active
- 2015-12-29 WO PCT/KR2015/014393 patent/WO2016108569A1/ko not_active Ceased
- 2015-12-29 AU AU2015372801A patent/AU2015372801B2/en active Active
-
2017
- 2017-07-04 SA SA517381861A patent/SA517381861B1/ar unknown
-
2019
- 2019-07-10 JP JP2019128325A patent/JP2019172702A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BR112017014224A2 (pt) | 2018-03-06 |
| JP6793996B2 (ja) | 2020-12-02 |
| JP2018503630A (ja) | 2018-02-08 |
| IL253218B (en) | 2022-08-01 |
| SA517381861B1 (ar) | 2021-09-08 |
| KR20160081827A (ko) | 2016-07-08 |
| NZ733388A (en) | 2018-11-30 |
| US20170369553A1 (en) | 2017-12-28 |
| RU2670166C1 (ru) | 2018-10-18 |
| EP3241849A1 (en) | 2017-11-08 |
| IL253218A0 (en) | 2017-08-31 |
| AU2015372801B2 (en) | 2018-12-20 |
| MX2017008633A (es) | 2018-04-26 |
| JP2019172702A (ja) | 2019-10-10 |
| US10988527B2 (en) | 2021-04-27 |
| AU2015372801A1 (en) | 2017-07-20 |
| KR102018608B1 (ko) | 2019-09-06 |
| EP3241849A4 (en) | 2018-06-20 |
| WO2016108569A1 (ko) | 2016-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR124871A2 (es) | Métodos de fabricación para el control del contenido de lisina c-terminal, galactosa y ácido siálico en proteínas recombinantes | |
| MX2016004564A (es) | Cultivo celular metabolicamente optimizado. | |
| BR112018002214A2 (pt) | ?métodos para cultivar células e para produzir uma proteína, meios de cultura de células cho e de batelada alimentada e/ou alimentação, e, alimentação de cultura de células cho? | |
| AR096713A1 (es) | Proceso de purificación para anticuerpos monoclonales | |
| MX384138B (es) | Anticuerpos anti-c5 y métodos para su uso. | |
| BR112018072946A2 (pt) | proteínas de fusão a gdf15 e usos das mesmas | |
| EA201491494A1 (ru) | Нацеливание на гликаны хондроитинсульфаты | |
| MX372711B (es) | Metodos para la purificacion de arilsulfatasa a. | |
| SA518391704B1 (ar) | C5 أجسام مضادة لـ وطرق لاستخدامها | |
| MX2019008914A (es) | Purificacion de iduronato-2-sulfatasa. | |
| EP4389143A3 (en) | Selective reduction of cysteine residues in il-17 antibodies | |
| BR112016028538A2 (pt) | processo de produção de proteína glicosilada, processos de produção de proteína de fusão e anticorpo monoclonal e fragmento do mesmo, processo de produção de proteína de fusão tnfr-fc, proteína de fusão ou anticorpo monoclonal e fragmento do mesmo | |
| MX383558B (es) | Cisteinas de anticuerpo con capuchon y sin capuchon y su uso en conjugacion de anticuerpo-farmaco | |
| PH12018501070A1 (en) | Anti-pcsk9 antibody and use thereof | |
| BR112018000168A2 (pt) | método para produção de células ips de alta qualidade | |
| MX394035B (es) | Procedimiento para preparar una proteina de fusion tnfr-fc que contiene un contenido objetivo de impurezas. | |
| BR112017020401A2 (pt) | processo de produção com íons de cobre controlados | |
| EA201591558A1 (ru) | Составы и способы увеличения производства рекомбинантного белка | |
| MX2013013063A (es) | Plantas que tienen rasgos mejorados relacionados con el rendimiento y metodo para elaborar las mismas. | |
| YU et al. | Charge heterogeneity analysis of monoclonal antibody products with imaging capillary isoelectric focusing electrophoresis | |
| TH171389A (th) | วิธีการสำหรับการเตรียมโปรตีนหลอมรวม tnfr-fc (tnfr-fc fusion protein) ที่ประกอบด้วยปริมาณเป้าหมายของสิ่งปนเปื้อน | |
| MX2023005172A (es) | Distribucion de casquetes de cisteina modificados. | |
| BR112017007795A2 (pt) | variantes do transportador gal2 e seus usos | |
| AR109237A1 (es) | Anticuerpos contra ip-10 y sus usos | |
| PL406374A1 (pl) | Sposób wydzielania 1,3-propanodiolu z brzeczki fermentacyjnej |